Characteristic | Initial treatment of ETV-Brand |
---|---|
Age, years | 61 (52.5–68.8) |
Male sex, n (%) | 119/175 (68.0%) |
BMI, kg/m2 | 24.3 (22.2–27) |
Period of ETV-Brand(years) | 3.2 (2.7–4.3) |
WBC, × 103/μL | 5.8 (4.4–7.3) |
HB, g/dL | 13.8 (12.7–14.6) |
Platelet, × 103/μL | 145 (104–191) |
ALT, U/L | 24 (18–32) |
AST, U/L | 29 (24–36) |
Total bilirubin, mg/dL | 0.8 (0.6–1.1) |
eGFR, mL/min/1.73 m2 | 81.8 (78.8–87.2) |
FIB-4 score | 2.7 (2.2–3.0) |
HBeAg-positive, n (%) | 34 (19.4%) |
Detectable HBV DNA level, IU/mL | 14.0 (12.4–16.5) |
Undetectable HBV DNA, n (%) | 142/175 (81%) |